Levodopa in Parkinsonism: The Effects of Withdrawal of Anticholinergic Drugs

BMJ
doi 10.1136/bmj.2.5760.487
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Levodopa in Parkinsonism

BMJ
1971English

The Use of Antipsychotic and Anticholinergic Antiparkinson Drugs in Norway After the Withdrawal of Orphenadrine

British Journal of Clinical Pharmacology
Pharmacology
2009English

Levodopa Withdrawal and the Neuroleptic Malignant Syndrome.

Postgraduate Medical Journal
Medicine
1986English

Antidiabetic Drugs in Parkinsonism

BMJ
1961English

6-Hydroxydopamine and Anticholinergic Drugs

Science
MultidisciplinaryPhilosophy of ScienceHistory
1978English

Anticholinesterases and Anticholinergic Drugs

Continuing Education in Anaesthesia Critical Care & Pain
2004English

Effects of Anticholinergic Drugs Used for the Therapy of Overactive Bladder on P-Glycoprotein Activity

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2019English

Idiopathic Parkinsonism Treated With an Extracerebral Decarboxylase Inhibitor in Combination With Levodopa

BMJ
1971English

Late-Onset Levodopa Responsive Parkinsonism Due to Polymerase Γ 1 Mutations

Movement Disorders Clinical Practice
Neurology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy